CFMS - Conformis, Inc.
| Previous Close | 0.5110 |
| Open | 0.5110 |
| Bid | 0.50 x 800 |
| Ask | 0.51 x 800 |
| Day's Range | 0.5000 - 0.5200 |
| 52 Week Range | 0.4200 - 2.8700 |
| Volume | 28,727 |
| Avg. Volume | 320,236 |
| Market Cap | 31.636M |
| Beta (3Y Monthly) | 0.89 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.83 |
| Earnings Date | Aug 1, 2018 - Aug 6, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.60 |
- GlobeNewswire•last month
New Research Coverage Highlights Penn National Gaming, PBF Logistics LP, Floor & Decor, Applied Industrial Technologies, ConforMIS, and SMART Global — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Nov. 06, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Thomson Reuters StreetEvents•last month
Edited Transcript of CFMS earnings conference call or presentation 31-Oct-18 8:30pm GMT
Q3 2018 Conformis Inc Earnings Call
- Zacks•last month
ConforMIS (CFMS) Reports Q3 Loss, Tops Revenue Estimates
ConforMIS (CFMS) delivered earnings and revenue surprises of 40.00% and 50.92%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•last month
ConforMIS: 3Q Earnings Snapshot
On a per-share basis, the Billerica, Massachusetts-based company said it had a loss of 12 cents. The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...
- GlobeNewswire•last month
Conformis Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Guidance
BILLERICA, Mass., Oct. 31, 2018 -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,.
- Zacks•2 months ago
ConforMIS (CFMS) Q3 Earnings Preview: How Are Events Shaping Up?
ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.•2 months ago
Have Investors Priced In Healthcare Growth For Conformis Inc (NASDAQ:CFMS)?
Conformis Inc (NASDAQ:CFMS), a US$58m small-cap, is a healthcare company operating in an industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as an Read More...
- GlobeNewswire•3 months ago
Conformis Announces Settlement of Patent Dispute with Smith & Nephew
BILLERICA, Mass., Sept. 17, 2018-- Conformis, Inc., a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants ...
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of CFMS earnings conference call or presentation 1-Aug-18 8:30pm GMT
Q2 2018 ConforMIS Inc Earnings Call
- Simply Wall St.•3 months ago
Do You Know Conformis Inc’s (NASDAQ:CFMS) Cash Situation?
Two important questions to ask before you buy Conformis Inc (NASDAQ:CFMS) is, how it makes money and how it spends its cash. This difference directly flows down to how muchRead More...
- Associated Press•4 months ago
ConforMIS: 2Q Earnings Snapshot
The Billerica, Massachusetts-based company said it had a loss of 24 cents per share. The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...
- Zacks•4 months ago
Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS
Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS
- InvestorPlace•4 months ago
5 Top-Ranked Stocks to Benefit From Rising P/E Investing
Generally, investors love stocks with a low price-to-earnings (P/E) ratio. The idea is that the lower the P/E, the higher will be the value of the stock. The simple logic that a stock’s current market price does not validate (is not equivalent to) its higher earnings and therefore has room to run justifies investors’ inclination toward low P/E stocks.Source: ©iStock.com/CharlieAJA
- Zacks•4 months ago
5 Top-Ranked Stocks to Benefit From Rising P/E Investing
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
- ACCESSWIRE•5 months ago
Free Technical Research on IsoRay and Three More Medical Supplies Equities
On Friday, July 20, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Taking into consideration last Friday's market sentiment, WallStEquities.com assessed the following Medical Instruments & Supplies equities this morning: IsoRay Inc. (NYSE AMER: ISR), STAAR Surgical Co. (NASDAQ: STAA), Conformis Inc. (NASDAQ: CFMS), and Integra LifeSciences Holdings Corp. (NASDAQ: IART).
- Simply Wall St.•5 months ago
When Will Conformis Inc (NASDAQ:CFMS) Become Profitable?
Conformis Inc’s (NASDAQ:CFMS): ConforMIS, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The US$76.75m market-cap company’s loss lessens since it announced a -US$53.58m bottom-line in theRead More...
- ACCESSWIRE•6 months ago
Initiating Free Research Reports on DENTSPLY SIRONA and Three Other Medical Supplies Equities
For today, WallStEquities.com assesses the recent performance of Conformis Inc. (NASDAQ: CFMS), DENTSPLY SIRONA Inc. (NASDAQ: XRAY), Illumina Inc. (NASDAQ: ILMN), and Integra LifeSciences Holdings Corp. (NASDAQ: IART). Companies in the Medical Instruments and Supplies manufacturing industry primarily research, develop, and produce non-electronic medical, surgical, dental, and veterinary instruments and apparatus.
